Ruxolitinib after fedratinib failure in patients with myelofibrosis: A real-world case series

Br J Haematol. 2024 Oct;205(4):1605-1609. doi: 10.1111/bjh.19654. Epub 2024 Jul 17.

F Palandri¹, F Branzanti², G Benevolo³, E Beggiato⁴, E Morsia⁵, A Dedola^{1

2}, M Loffredo^{1

2}, G Fontana^{1

2}, G A Palumbo⁶, M Breccia⁷, M Tiribelli⁸

¹ IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy.
² Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy.
³ University Hematology Division, Città della Salute e della Scienza Hospital, Torino, Italy.
⁴ Unit of Hematology, Department of Oncology, University of Torino, Torino, Italy.
⁵ Hematology Unit, Department of Clinical and Molecular Sciences, DISCLIMO, Università Politecnica delle Marche, Ancona, Italy.
⁶ Department of Scienze Mediche, Chirurgiche e Tecnologie Avanzate "G.F. Ingrassia", University of Catania, Catania, Italy.
⁷ Hematology, Department of Translational and Precision Medicine, Az. Policlinico Umberto I-Sapienza University, Rome, Italy.
⁸ Division of Hematology and BMT, Department of Medicine, University of Udine, Udine, Italy.

No abstract available

Publication types